Docetaxel-induced severe neuropathy, a case of breast cancer with GTSP1 polymorphism.

Ezgi Değerli

Published in: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2024)

This case underscores the importance of recognizing severe DIPN, even in atypical patient profiles. Genetic factors, like GSTP1 polymorphisms, may contribute to DIPN risk. Large-scale studies are crucial to establishing the significance of these genetic variations in DIPN susceptibility.

Keyphrases

genome wide
drug induced
early onset
copy number
high glucose
case report
squamous cell carcinoma
locally advanced
radiation therapy
case control
breast cancer risk